S 3231 (see companion bill A 832) – New York
Introduced: 2021 Status: In Process
Relates to certain prohibitions in contracts or agreements by health maintenance organizations; prohibits clauses which entitle reimbursement at the lowest price or rate; prohibits contracts which restrict referral of patients based solely upon a health …
S 3746 (see companion bill A 999) – New Jersey
Introduced: 2019 Status: Inactive / Dead
Restricts certain practices by carriers and pharmacy benefits managers related to medications and drugs. Place certainrequirements on carriers and pharmacy benefits managers in situations in which a covered person’s prescribed medication is switched to a …
S 5471 (see companion bill A 236) – New York
Introduced: 2017 Status: Inactive / Dead
REQUIRES THE COMMISSIONER OF HEALTH TO ESTABLISH AND PUBLISH A LIST OF GENERIC DRUG PRODUCTS: The commissioner shall establish and publish a list of drug products matched to brand name drugs with which they have …
S 640 (see companion bill H 1055) – Massachusetts
Introduced: 2019 Status: Inactive / Dead
For legislation to ensure access to generic medications. Financial Services.
SB 100 (see companion bill AB 114) – Wisconsin
Introduced: 2019 Status: Inactive / Dead
Registration and regulation of pharmacy benefit managers, drug pricing transparency, granting rule-making authority, and providing a penalty. The bill requires pharmacy benefit managers to provide a reasonably adequate and accessible network of pharmacies. The bill …
SB 1393 – Arizona
Introduced: 2019 Status: Inactive / Dead
Coverage; formulary; changes prohibited; diabetes: An Act amending sections 20-841.05 and 20-1057.02, Arizona revised statutes; amending title 20, chapter 6, article 4, Arizona revised statutes, by adding section 20-1342.07; amending title 20, chapter 6, article …
SB 166 – Rhode Island
Introduced: 2021 Status: Inactive / Dead
AN ACT RELATING TO BUSINESSES AND PROFESSIONS — PHARMACIES: Provides that pharmacists shall disclose lesser price drug substitutions unless directed otherwise by the doctor. Exempts pharmacists automatically charging the lowest available price.
SB 245 – Alabama
Introduced: 2019 Status: Enacted
This bill would authorize a licensed pharmacist to dispense a substitute interchangeable biological product for certain biological products under certain conditions.
SB 3545 – Illinois
Introduced: 2020 Status: Inactive / Dead
INS/ANTI-SEIZURE DRUG COVERAGE. Amends the Illinois Insurance Code. Provides that an individual or group policy of accident and health insurance amended, delivered, issued, or renewed after the effective date of the amendatory Act shall provide …
SB 3733 – Illinois
Introduced: 2020 Status: Inactive / Dead
INS-GENERIC PRESCRIPTION DRUGS. Amends the Illinois Insurance Code. Provides that if a generic equivalent for a brand name drug is approved by the Food and Drug Administration, insurance companies with plans that provide coverage for …
SB 39 – Alabama
Introduced: 2019 Status: Inactive / Dead
Relating to pharmacists and the requirements for prescriptions and the dispensing of prescriptions; to amend Section 34-23-8 of the Code of Alabama 1975, to specify that, unless a physician or other practitioner indicates otherwise, a …
SB 487 – Rhode Island
Introduced: 2021 Status: Inactive / Dead
AN ACT RELATING TO BUSINESSES AND PROFESSIONS — PHARMACIES — PRESCRIPTIONS: Requires pharmacists to notify their customers whether their cost sharing benefits exceed the actual retail price of the prescription sought.
SB 5601 (see companion bill HB 1562) – Washington
Introduced: 2019 Status: Enacted
CONCERNING HEALTH CARE BENEFIT MANAGEMENT. A health care benefit manager doing business as a pharmacy may not place a drug on a list unless there are at least two therapeutically equivalent multiple source drugs, or …
SB 844 – Oregon
Introduced: 2021 Status: Enacted
Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for nine drugs and at least one insulin product, from among drugs reported to Prescription Drug Price Transparency program by …
SB 879 – Oklahoma
Introduced: 2023 Status: In Process
provides that pharmacy benefits manager (PBM) contracts shall not prohibit from or penalize for a pharmacy or pharmacist disclosing to an individual information regarding the existence and clinical efficacy of a generic equivalent nor shall …
SF 2222 (see HF 1872) – Minnesota
Introduced: 2019 Status: Inactive / Dead
Prescription drug education program establishment and appropriation. The commissioner of human services, in collaboration with the Board of Pharmacy, the University of Minnesota Medical School, and the University of Minnesota College of Pharmacy, shall develop …